|
Novel |
ABCD1 |
ATP binding cassette subfamily D member 1 |
- ABC transporters in lipid homeostasis
- Linoleic acid (LA) metabolism
- alpha-linolenic acid (ALA) metabolism
- Beta-oxidation of very long chain fatty acids
- Defective ABCD1 causes ALD
- Class I peroxisomal membrane protein import
|
|
- Adrenoleukodystrophy (ALD), including: Schilder-Addison Complex; Childhood cerebral adrenoleukodystrophy (CCER); adrenomyeloneuropathy (AMN)
|
|
Novel |
CETN2 |
centrin 2 |
- Regulation of PLK1 Activity at G2/M Transition
- SUMOylation of DNA damage response and repair proteins
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- DNA Damage Recognition in GG-NER
- Formation of Incision Complex in GG-NER
- AURKA Activation by TPX2
|
|
|
|
Novel |
CTAG1B |
cancer/testis antigen 1B |
|
|
|
|
Novel |
LARP1 |
La ribonucleoprotein 1, translational regulator |
|
|
|
|
Novel |
NT5E |
5'-nucleotidase ecto |
- Nicotinate metabolism
- Pyrimidine catabolism
- Purine catabolism
- Purinergic signaling in leishmaniasis infection
|
|
- Calcification of joints and arteries
|
|
|
ANG |
angiogenin |
- Adherens junctions interactions
|
|
- Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
|
|
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
- Signaling by ERBB2
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PLCG1 events in ERBB2 signaling
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Downregulation of ERBB2:ERBB3 signaling
- GRB2 events in ERBB2 signaling
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- Sema4D induced cell migration and growth-cone collapse
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Downregulation of ERBB2 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
- Constitutive Signaling by Overexpressed ERBB2
- Drug-mediated inhibition of ERBB2 signaling
- Signaling by ERBB2 KD Mutants
- Resistance of ERBB2 KD mutants to trastuzumab
- Resistance of ERBB2 KD mutants to sapitinib
- Resistance of ERBB2 KD mutants to tesevatinib
- Resistance of ERBB2 KD mutants to neratinib
- Resistance of ERBB2 KD mutants to osimertinib
- Resistance of ERBB2 KD mutants to afatinib
- Resistance of ERBB2 KD mutants to AEE788
- Resistance of ERBB2 KD mutants to lapatinib
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
- Drug resistance in ERBB2 TMD/JMD mutants
|
- Trastuzumab
- Lapatinib
- IGN311
- Trastuzumab emtansine
- Varlitinib
- AV-412
- Pertuzumab
- Afatinib
- Tucatinib
- Tesevatinib
- Fostamatinib
- Brigatinib
- Margetuximab
- Zanubrutinib
|
- Choriocarcinoma
- Pancreatic cancer
- Gastric cancer
- Bladder cancer
- Endometrial Cancer
- Ovarian cancer
- Cholangiocarcinoma
- Breast cancer
- Cervical cancer
|
|
|
HBA1 |
hemoglobin subunit alpha 1 |
- Erythrocytes take up carbon dioxide and release oxygen
- Erythrocytes take up oxygen and release carbon dioxide
- Scavenging of heme from plasma
|
- Iron Dextran
- Iron
- Zinc
- 4-Carboxycinnamic Acid
- Pentaerythritol tetranitrate
- 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine
- 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine
- Sebacic acid
- 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID
- 2,6-dicarboxynaphthalene
- Efaproxiral
- Trimesic acid
- Nitrous acid
- Copper
- Ferric pyrophosphate
- Sodium ferric gluconate complex
- Ferrous sulfate anhydrous
- Ferric pyrophosphate citrate
- Zinc acetate
- Ferrous gluconate
- Ferrous succinate
- Ferrous ascorbate
- Ferrous fumarate
- Ferrous glycine sulfate
- Zinc chloride
- Zinc sulfate, unspecified form
- Voxelotor
- Ferric derisomaltose
|
- Thalassemia; Alpha thalassemia; Beta thalassemia; Alpha thalassemia, X-linked (ATRX)
|
|
|
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
|
- Vitamin E
- Oxiconazole
- Phenytoin
- Diethylstilbestrol
- Clotrimazole
- Pentobarbital
- Spironolactone
- Lindane
- Flutamide
- Ritonavir
- Erlotinib
- Cyclophosphamide
- Mephenytoin
- Carbamazepine
- Tamoxifen
- Warfarin
- Ethotoin
- Estradiol
- Mifepristone
- Methylphenobarbital
- Ethinylestradiol
- Ketoconazole
- Fenofibrate
- Rifampicin
- Clonazepam
- Miconazole
- Nifedipine
- Econazole
- Sulfinpyrazone
- Phenobarbital
- Ifosfamide
- Rifaximin
- Paclitaxel
- Dexamethasone
- Docetaxel
- Bezafibrate
- Genistein
- Prasterone
- Hyperforin
- Resveratrol
- Pregnenolone
- Quercetin
- SR12813
- Afimoxifene
- Phenolphthalein
- Permethrin
- Dovitinib
- Chenodeoxycholic acid
- TO-901317
- Hexestrol
- Triclosan
- Rilpivirine
- Pyrethrum extract
- Myrrh
- Piperine
- Troleandomycin
- Fenofibric acid
- Estradiol acetate
- Estradiol benzoate
- Estradiol cypionate
- Estradiol dienanthate
- Estradiol valerate
- alpha-Tocopherol succinate
- D-alpha-Tocopherol acetate
- Dexamethasone acetate
|
|
|
|
RHOU |
ras homolog family member U |
- Rho GTPase cycle
- Interleukin-4 and Interleukin-13 signaling
|
|
|